Ferroptosis: A new strategy for targeting Alzheimer's disease

被引:0
|
作者
Qiang, Rong Rong [1 ]
Xiang, Yang [2 ]
Zhang, Lei [1 ]
Bai, Xin Yue [1 ]
Zhang, Die [1 ]
Li, Yang Jing [1 ]
Yang, Yan Ling [1 ]
Liu, Xiao Long [1 ]
机构
[1] Yanan Univ, Sch Med, Yanan, Peoples R China
[2] Yanan Univ, Coll Phys Educ, Yanan 716000, Shaanxi, Peoples R China
关键词
Alzheimer's disease; Ferroptosis; Lipid peroxidation; Ferroptosis inhibitor; AMYLOID PRECURSOR PROTEIN; MEMBRANE PHOSPHOLIPID ALTERATIONS; MILD COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; APOLIPOPROTEIN-E; MEMORY DEFICITS; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; SYNAPTIC PLASTICITY; LIPID-PEROXIDATION;
D O I
10.1016/j.neuint.2024.105773
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a complex pathogenesis, which involves the formation of amyloid plaques and neurofibrillary tangles. Many recent studies have revealed a close association between ferroptosis and the pathogenesis of AD. Factors such as ferroptosis-associated iron overload, lipid peroxidation, disturbances in redox homeostasis, and accumulation of reactive oxygen species have been found to contribute to the pathological progression of AD. In this review, we explore the mechanisms underlying ferroptosis, describe the link between ferroptosis and AD, and examine the reported efficacy of ferroptosis inhibitors in treating AD. Finally, we discuss the potential challenges to ferroptosis inhibitors use in the clinic, enabling their faster use in clinical treatment.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Targeting Mitophagy in Alzheimer's Disease
    Jayatunga, Dona P. W.
    Hone, Eugene
    Bharadwaj, Prashant
    Garg, Manohar
    Verdile, Giuseppe
    Guillemin, Gilles J.
    Martins, Ralph N.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (04) : 1273 - 1297
  • [42] Targeting the Synapse in Alzheimer's Disease
    Jackson, Johanna
    Jambrina, Enrique
    Li, Jennifer
    Marston, Hugh
    Menzies, Fiona
    Phillips, Keith
    Gilmour, Gary
    [J]. FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [43] Targeting γ-secretase for Alzheimer's disease
    Wolfe, Michael S.
    [J]. Alzheimer: 100 Years and Beyond, 2006, : 265 - 268
  • [44] Targeting PPARalpha in Alzheimer's Disease
    D'Orio, Barbara
    Fracassi, Anna
    Ceru, Maria Paola
    Moreno, Sandra
    [J]. CURRENT ALZHEIMER RESEARCH, 2018, 15 (04) : 345 - 354
  • [45] Targeting Alzheimer's Disease With Aducanumab
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (06) : 580 - 580
  • [46] A New Paradigm for the Treatment of Alzheimer's Disease: Targeting Vascular Activation
    Grammas, Paula
    Martinez, Joseph
    Sanchez, Alma
    Yin, Xiangling
    Riley, Jarred
    Desobry, Katherine
    Tripathy, Debjani
    Luo, Jinhua
    Evola, Marianne
    Young, Alice
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 40 (03) : 619 - 630
  • [47] New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease
    David, Michael
    Malhotra, Paresh A.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2022, 9 (04): : 582 - 596
  • [48] Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease
    Minnella, Angela
    McCusker, Kevin P.
    Amagata, Akiko
    Trias, Beatrice
    Weetall, Marla
    Latham, Joey C.
    O'Neill, Sloane
    Wyse, Richard K.
    Klein, Matthew B.
    Trimmer, Jeffrey K.
    [J]. PLOS ONE, 2024, 19 (09):
  • [49] Targeting Post-translational Modifications on Tau as a Therapeutic Strategy for Alzheimer's Disease
    Marcus, Jacob Newman
    Schachter, Joel
    [J]. JOURNAL OF NEUROGENETICS, 2011, 25 (04) : 127 - 133
  • [50] Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
    Caldwell, Andrew B.
    Liu, Qing
    Zhang, Can
    Schroth, Gary P.
    Galasko, Douglas R.
    Rynearson, Kevin D.
    Tanzi, Rudolph E.
    Yuan, Shauna H.
    Wagner, Steven L.
    Subramaniam, Shankar
    [J]. ALZHEIMERS & DEMENTIA, 2022, 18 (11) : 2117 - 2130